Ripe for innovation
The pandemic accelerated the adoption of both technologies and new approaches to the conduct of clinical research. We help ensure the best of those advancements become the new best practices.
Today we bring the trial to the patient. We design trials that seamlessly mesh with patients’ day-to-day activities and capture important trial information while reducing the burden on both patients and investigators.
COSTA PANAGOS, President,
Research & Development Solutions
Lesson Learned from COVID-19 Vaccine Trials
This report explores model changes that allowed for clinical trial efficiencies from the perspective of the CRO and is based on a set of workshops with COVID-19 vaccine clinical delivery teams. Our emphasis is on understanding what was possible because of the drastic operating environment changes and assessing what can be carried forward into the post-pandemic clinical development pipeline of therapies for other illnesses.
The intersection of technology, data and patients
Technology advancements are allowing data collection in new and less obtrusive ways to the patient. Combined with decentralized models and advanced patient engagement tools, patient-centric drug development is now a reality.
